Cargando…
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
The blood–brain barrier acts as a physical barrier that prevents free entry of blood-derived substances, including those intended for therapeutic applications. The development of molecular Trojan horses is a promising drug targeting technology that allows for non-invasive delivery of therapeutics in...
Autores principales: | Georgieva, Julia V., Hoekstra, Dick, Zuhorn, Inge S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279133/ https://www.ncbi.nlm.nih.gov/pubmed/25407801 http://dx.doi.org/10.3390/pharmaceutics6040557 |
Ejemplares similares
-
Intracellular transport and regulation of transcytosis across the blood–brain barrier
por: Villaseñor, Roberto, et al.
Publicado: (2018) -
Overview of Crosstalk Between Multiple Factor of Transcytosis in Blood Brain Barrier
por: Tjakra, Marco, et al.
Publicado: (2020) -
Drug Smuggling and Taking in India and Burma
Publicado: (1922) -
Overview of Current Drug Delivery Methods Across the Blood–Brain Barrier for the Treatment of Primary Brain Tumors
por: Haumann, Rianne, et al.
Publicado: (2020) -
Syndapin-2 mediated transcytosis of amyloid-β across the blood–brain barrier
por: M. Leite, Diana, et al.
Publicado: (2022)